Canada Veterinary Biomarkers Market

Canada Veterinary Biomarkers Market Insights Forecasts to 2035

• The Canada Veterinary Biomarkers Market Size was estimated at USD 50.36 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 8.36% from 2025 to 2035
• The Canada Veterinary Biomarkers Market Size is Expected to Reach USD 121.78 Million by 2035

According to a research report published by Spherical Insights and Consulting, the Canada Veterinary Biomarkers Market is anticipated to reach USD 121.78 million by 2035, growing at a CAGR of 8.36% from 2025 to 2035. The need for biomarker-based assay diagnostic kits in veterinary applications to predict disease in its early stages is significantly rising due to the rising incidence of chronic conditions in animals, such as cancer and cardiovascular diseases. The market is expanding as major corporations advance R&D initiatives to expand their biomarker portfolios.

Market Overview

The market for veterinary biomarkers in Canada is the sector of veterinary diagnostics that focuses on finding biological indicators, or biomarkers, in animals, particularly companion animals like dogs and cats, in order to identify, track, and treat illnesses like cancer, infections, and genetic disorders. Veterinary biomarkers are quantifiable markers of disease conditions, healthy biological processes, or an animal's reaction to therapy. They may consist of molecules, cells, genes, or other biological traits that can be measured objectively in order to evaluate the health of animals. In veterinary medicine, these biomarkers are crucial for prognosis, drug development, early disease detection, and individualised treatment regimens. Further, in June 2025 announcement of a $3.4 million funding commitment over four years serves as an example of Canadian government investment in veterinary biomarkers. The Omics Resource Centre at the Western College of Veterinary Medicine (WCVM) and the Beef Reprotech facilities at the Livestock and Forage Centre of Excellence (LFCE) are two new facilities being developed at the University of Saskatchewan (USask) with the help of this investment. By connecting genomic markers to desirable traits and enhancing beef cattle's reproductive efficiency, this funding supports integrated genomics research for animals.

Report Coverage

This research report categorises the market for the Canada veterinary biomarkers market based on various segments and regions, and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Canada veterinary biomarkers market. Recent market developments and competitive strategies, such as expansion, product launch, development, partnership, merger, and acquisition, have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Canada veterinary biomarkers market.

Driving Factors

The market for veterinary biomarkers is expanding quickly due to rising pet ownership, greater knowledge of animal health, and advancements in diagnostic technology. The market is expanding as a result of rising livestock production, a rise in zoonotic disease incidence, and the necessity of early disease detection. The demand for quick, accurate, and portable diagnostic tools is growing. Advances in telemedicine, biosensors, and AI-driven diagnostics are transforming veterinary healthcare by enabling faster and more accurate diagnoses. The industry will probably grow dramatically in the future as a result of growing investments in animal healthcare and continuous technological advancements.

Restraining Factors

The veterinary biomarkers market in Canada has strong growth potential, but it is constrained by a number of factors, such as the high expenses of biomarker assays and advanced diagnostic technologies prevent their widespread use. The market also faces regulatory obstacles, making things more complicated, as new biomarker kit approvals and commercialisation.

Market Segmentation

The Canada veterinary biomarkers market share is classified into product type and application.

• The kits segment dominated the market in 2024 and is anticipated to grow at a significant CAGR during the forecast period.

The Canada veterinary biomarkers market is segmented by product type into readers, kits, and reagents. Among these, the kits segment dominated the market in 2024 and is anticipated to grow at a significant CAGR during the forecast period. Veterinarians place a high value on accurate and sensitive diagnostic methods made possible by biomarker test kits. These kits are essential for monitoring the course of diseases and delivering biologically based targeted treatments. One of the main factors propelling the segment's growth is the growing use of biomarkers for the diagnosis and treatment of animal diseases.

• The clinical segment held a significant share in 2024 and is expected to grow at a rapid pace during the forecast period.

The Canada veterinary biomarkers market is segmented by application into clinical treatment and research. Among these, the clinical segment held a significant share in 2024 and is expected to grow at a rapid pace during the forecast period. Its crucial role in disease diagnosis, treatment monitoring, and prognosis evaluation across a range of animal species is what propels the clinical application segment's dominance. In animals, biomarkers help with early diagnosis and accurate tracking of diseases like cancer, heart disease, and infectious diseases. Furthermore, developments in biomarker technologies, rising demand for precise diagnostic instruments, and the growing global adoption of personalised veterinary medicine practices are driving the segment's expansion.

Competitive Analysis:

The report offers the appropriate analysis of the key organisations/companies involved within the Canada veterinary biomarkers market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

          Biovet Inc

           Prevtec Microbia

• BioAgriMix
• Vetoquinol N.-A. Inc.
• IDEXX Canada
• Others

Recent Developments:

• In January 2025, IDEXX launched Cancer Dx, a first-of-its-kind diagnostic panel offering affordable early detection of canine lymphoma, with plans to expand coverage to most canine cancers over the next three years. Dogs with canine lymphoma may live longer and have a better quality of life if they receive treatment, which emphasises how important early detection and intervention are to improving results.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at the Canada, regional, and country levels from 2020 to 2035.decision advisor has segmented the Canada Veterinary Biomarkers Market based on the below-mentioned segments:

Canada Veterinary Biomarkers Market, By Product Type

• Readers
• Kits
• Reagents

Canada Veterinary Biomarkers Market, By Application

• Clinical treatment
• Research

FAQ

1. What was the market size of the Canadian Veterinary Biomarkers Market in 2024?

The market size was estimated at USD 50.36 million in 2024.

2. What is the expected growth rate for the Canadian Veterinary Biomarkers Market?

The market is forecasted to grow at a CAGR of around 8.36% from 2025 to 2035.

3. What is the projected market size by 2035?

The market is expected to reach USD 121.78 million by 2035.

4. Which product segment held the largest market share in 2024?

The kits segment dominated the market in 2024 and is expected to grow significantly during the forecast period.

5. Which application segment held the largest share in 2024?

The clinical treatment application held a significant share and is expected to grow rapidly.

6. What are the key factors driving market growth?

Growth is driven by increasing pet ownership, rising incidence of chronic diseases such as cancer and cardiovascular conditions in animals, advancements in diagnostic technologies, including telemedicine and AI, and government investments to support integrated genomic research and biomarker development.

7. Who are the major players in the Canadian Veterinary Biomarkers Market?

Key companies include Biovet Inc., Prevtec Microbia, BioAgriMix, Vetoquinol N.-A. Inc., IDEXX Canada, and others.